📰 Recommended Phase News
Recommended Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Recommended Phase. Real-time updates on events, politics, business and more.
May 6, 2024
6 May 2024 ORYZON reports financial results and corporate update for quarter ended March 31, 2024 Finalizing full data analysis from...
April 24, 2024
BrightRock Gold Corp. Releases Phase 1 Exploration Report on the Midnight ...
April 8, 2024
/PRNewswire/ -- Immunitas Therapeutics ("Immunitas"), a clinical stage precision immunotherapy company committed to discovering and developing novel,...
April 3, 2024
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that through its collaboration agreement with a...
January 19, 2024
/PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of...
December 18, 2023
First patient dosed in Australia where 3 clinical trial sites have been activated.The trial will enrol advanced colorectal cancer patients whose cancer...
October 31, 2023
/PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation,...
October 27, 2023
27.10.2023 - Positive aggregate safety data from vafidemstats fully enrolled PORTICO Phase IIb trial in Borderline Personality Disorder (BPD), consistent with safety data from seven completed clinical trials, supporting the drug is safe and ...
October 22, 2023
Across all 86 heavily pretreated patients, the median PFS was 4.6 months with a CBR of 40%; in patients with ESR1 mutations at baseline, the median PFS was...
October 22, 2023
Across all 86 heavily pretreated patients, the median PFS was 4.6 months with a CBR of 40%; in patients with ESR1 mutations at baseline, the median PFS was 5.6 months with a CBR of 52% In an analysis of 49 second- and